Synthesis and human carbonic anhydrase I, II, VA, and XII inhibition with novel amino acid-sulphonamide conjugates.
Clicks: 281
ID: 81873
2020
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Popular Article
73.3
/100
281 views
225 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
A series of amino acid-sulphonamide conjugates was prepared through benzotriazole mediated coupling reactions and characterised by H-NMR, C-NMR, MS, and FTIR spectroscopic techniques as well as elemental analysis. The carbonic anhydrase (CA, EC 4.2.1.1) inhibitory activity of the new compounds was determined against four human (h) isoforms, hCA I, hCA II, hCA VA, and hCA XII. Most of the synthesised compounds showed effective CA inhibitory properties. The new amino acid-sulphonamide conjugates showed potent inhibitory activity against hCA II, some of them at subnanomolar levels, exhibiting more effective inhibitory activity compared to the standard drug acetazolamide. Some of these sulphonamides were also found to be effective inhibitors of hCA I, hCA VA, and hCA XII, with activity from the low to high nanomolar range.Reference Key |
kucukbay2020synthesisjournal
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
---|---|
Authors | Küçükbay, Hasan;Buğday, Nesrin;Küçükbay, F Zehra;Ageli, Andrea;Bartolucci, Gianluca;Supuran, Claudiu T; |
Journal | Journal of enzyme inhibition and medicinal chemistry |
Year | 2020 |
DOI | 10.1080/14756366.2019.1710503 |
URL | |
Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.